News
- January 11, 2010
Thallion Announces Changes to Executive Management Structure and Board of Directors
- December 18, 2009
Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs®
- December 18, 2009
Thallion Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data

